stemsavelogo

Select Country

877-783-6728 (877-StemSave)

StemSave Blog

Epidermolysis Bullosa Treated Utilizing Patient’s Own Stem Cells

Posted by taylor@stemsave.com on Feb 5, 2014 9:12:21 AM

Scientists are utilizing the patient's own stem cells to correct the defective EB gene.

Researchers at the University of Modena and Reggio Emilia in Italy have recently developed a method for treating patients with the genetic skin disease Epidermolyisis Bullosa (EB). The process is an example of translational genomics, in which the researchers extract autologous (the patient’s own) stem cells, correct the defective gene that caused the EB, and then transplant the cells back into the patient.

In addition to being quite painful, EB causes blisters and fragile skin, which can lead to life-threatening infections. Utilizing the patient’s own stem cells prevents these symptoms by treating the source of the disease, i.e. the defective gene, without running the risk of the immune system rejecting donated cells.

The research is an example of how scientists are utilizing the patient’s own stem cells to create more effective regenerative treatments leading to better outcomes. To learn more about the value of preserving your own stem cells for use in future regenerative therapies, visit StemSave or call 877-783-6728 (877-StemSave) today.

 

 
To view the full abstract, click here.

 

 

The Future of Regenerative Medicine is Now™.

 

Topics: Skin, stemsaveblog, clinical trials, Stemcells, autologousstemcells

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

    Recent Posts

    Posts by Topic

    see all